Please assess the completion status of the following clinical trial:

Trial Title: A Pilot Study to Evaluate the Contribution of the Saphenous Nerve in Ankle Pain of Patients With Degenerative Joint Disease of the Ankle

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients evaluated with osteoarthritis who are surgical candidates for ankle fusion or total ankle replacement.~* Registered patients at Mayo Clinic in Florida with scheduled visit to see Dr.Whalen~Exclusion Criteria:~* Patients with lower extremity diabetic neuropathy~* History of prior trauma of ankle with residual nerve injury~* Current medication of pregabalin or gabalin~* Allergy to lidocaine.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- Saphenous nerve block (Type: None): Data collection after saphenous nerve block placement

Based on this trial design, predict the completion outcome and termination type (if applicable).